Stay updated on IDA53 Clinical Trial
Sign up to get notified when there's something new on the IDA53 Clinical Trial page.

Latest updates to the IDA53 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe Study Details page now uses the official IDA53/FILO naming, including 'A Phase II Pilot Study... IDA53 Trial. A FILO Study.' The older phrasing has been replaced with the updated identifiers.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check48 days agoChange DetectedThe government funding/operational status notice was removed from the page. Core study details and eligibility information are unchanged.SummaryDifference0.3%

- Check62 days agoChange DetectedNo significant changes detected between the two screenshots; core study details such as the title, NCT number, objectives, enrollment, and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government operating status notice and updated to revision v3.2.0. - Removed the Genetic and Rare Diseases Information Center resource for B-cell chronic lymphocytic leukemia; version tacked from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to IDA53 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDA53 Clinical Trial page.